Steg PG, Mesnier J. Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation Receiving Oral Antiplatelet Therapy: Definitely Safe, but How Effective? Circulation 2025;152:297-299.
PMID: 40758773